- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Northvale Today
By the People, for the People
ADM Tronics Reports Third Quarter of Fiscal Year 2026 Results
Technology company sees revenue growth and progress on new medical device development
Published on Feb. 13, 2026
Got story updates? Submit your updates here. ›
ADM Tronics Unlimited, Inc., a technology-based developer and manufacturer of innovative products, has announced its financial results for the third quarter of fiscal year 2026. The company reported a 9% increase in revenues for the nine months ended December 31, 2025, as well as a 7% increase in revenues for the three-month period compared to the same time last year. ADM Tronics also provided an update on the development of its proprietary non-invasive musculoskeletal pain therapy medical device, which is currently undergoing engineering development before the company plans to submit a 510(k) Pre-Market Notification to the FDA.
Why it matters
As a diversified technology company, ADM Tronics' financial performance and product development progress provide insight into the broader trends in the medical device and technology manufacturing industries. The company's ability to grow revenues and advance its pipeline of innovative products suggests it is well-positioned to capitalize on emerging market opportunities.
The details
For the three months ended December 31, 2025, ADM Tronics reported revenues of $803,088, up 8% from $749,510 in the same period the prior year. The company also reported a loss from operations of $84,441 for the quarter, compared to a loss of $89,269 in the year-ago period. For the nine months ended December 31, 2025, revenues increased 9% to $2,664,261 from $2,447,391 in the same period of fiscal year 2025. Income from operations for the nine-month period was $27,346, compared to $29,154 in the prior-year period. The company said its research and development activity and expense are continuing on its proprietary non-invasive musculoskeletal pain therapy medical device, and it plans to submit a 510(k) Pre-Market Notification to the FDA for clearance to market the device once engineering development is completed.
- For the three months ended December 31, 2025
- For the nine months ended December 31, 2025
The players
ADM Tronics Unlimited, Inc.
A technology-based developer and manufacturer of innovative technologies and products, with three areas of activity: Proprietary Electronic Medical Devices; Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Safe, Water-Based Formulations.
What’s next
When engineering development is completed, the Company intends to submit a 510(k) Pre-Market Notification to the FDA for clearance to market its proprietary non-invasive musculoskeletal pain therapy medical device.
The takeaway
ADM Tronics' continued revenue growth and progress on developing its innovative medical device technology suggest the company is well-positioned to capitalize on emerging opportunities in the medical device and technology manufacturing industries.
